Skip to content
Events
Advances in Genome Biology and Technology

Details

Advances in Genome Biology and Technology (AGBT) is considered the preeminent genome science and technology conference where top global researchers, leaders, and innovators meet to announce new discoveries and cutting-edge breakthroughs and to collaborate. As a recognized cornerstone for the genomics research community, AGBT provides an outstanding forum for exchanging information about the latest advances in DNA sequencing technologies, experimental and analytical approaches for genomic studies, and their myriad applications. The meeting format includes daytime plenary sessions that feature invited speakers and abstract-selected talks that highlight cutting-edge research across the broad landscape of genomics. The evening concurrent session includes experimental and computational approaches for effectively utilizing the latest DNA sequencing technologies.

Join Illumina in the Illumina Lounge 214, to see and demo the NovaSeq X and NextSeq 1000/2000, attend our Spotlight Talks, and speak to Illumina specialists.

Schedule of Illumina events
Tuesday, February 7

8 AM – 9 AM (ET)
Spotlight Talk: NovaSeq X series — This is the genome era
Location: Illumina Lounge 214

Kim Busiek

Kim Busiek, PhD
Associate Director, Product Management
Illumina

Wednesday, February 8

8 AM – 9 AM (ET)
Spotlight Talk: Advancements in whole genome sequencing
Location: Illumina Lounge 214

Mike Lelivelt

Mike Lelivelt, PhD
VP Product Management, Software & Informatics
Illumina

Andrew Shaver

Andrew Shaver
Sr. Manager, Product Management
Illumina

12 PM – 1 PM (ET)
Workshop: NovaSeq X and innovations across the Illumina portfolio
Location: Great Hall 4–6

Niall Lennon

Niall Lennon, PhD
Senior Director of Translational Genomics and Institute Scientist
The Broad Institute of MIT and Harvard

Alex Aravanis

Alex Aravanis, PhD
Chief Technology Officer, Senior Vice President, Head of Research and Product Development
Illumina

Fiona Nohilly

Moderator: Fiona Nohilly
Sr Manager, Product Marketing
Illumina

Thursday, February 9

8 AM – 9 AM (ET)
Spotlight Talk: NextSeq 1000 and 2000 Product updates and key applications
Location: Illumina Lounge 214

Sam Hester

Sam Hester
Sr. Product Marketing Manager
Illumina

M-US-00338

Date & Time
Feb 6, 2023 – Feb 9, 2023
Location
Hollywood, Florida
United States
Topic
Instruments, Sequencing reagents & flow cells, Software & informatics

Related Events

Feb 26
Illumina’s Integrated Workflow for Rare and Undiagnosed Genetic Disease Research
Feb 26, 2025
Individuals suspected of having a rare disease often face a long search for an answer. With up to 80% of rare diseases being genetic or having a genetic subtype, it is imperative to interrogate the genome to find answers and shorten the diagnostic odyssey. This webinar provides an overview of the integrated workflow provided by Illumina for rare and undiagnosed diseases research. Starting from library prep to sequencing and informatics, Illumina empowers researchers to find the answers they seek in rare and undiagnosed disease research.
View Event
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see www.illumina.com/company/legal.html.

© 2025 Illumina, Inc. All rights reserved.